NCT04008914 is a clinical trial of retrospective observation in Heart Failure, sponsored by Ascension Macomb-Oakland Hospital.

Who is sponsoring NCT04008914?

NCT04008914 is sponsored by Ascension Macomb-Oakland Hospital.

What drugs are being tested in NCT04008914?

Interventions in NCT04008914: retrospective observation.

What condition does NCT04008914 study?

NCT04008914 studies Heart Failure, Preserved Ejection Fraction.

Is NCT04008914 still recruiting?

NCT04008914 is currently completed. Last updated 8 July 2019.

Last reviewed 2019-07-08 · How we verify

NCT04008914

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Readmission Risk Factors and Heart Failure With Preserved Ejection Fraction

Completed Last updated 8 July 2019

What this trial tests

trial testing retrospective observation in Heart Failure in 492 participants. Completed in 18 January 2019.

Timeline

1 August 2017

Primary endpoint
1 March 2018

18 January 2019

Quick facts

Lead sponsor	Ascension Macomb-Oakland Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	492
Start date	1 August 2017
Primary completion	1 March 2018
Estimated completion	18 January 2019
Sites	1 location across United States

Drugs / interventions tested

retrospective observation

Conditions studied

Heart Failure — all drugs for Heart Failure →
Preserved Ejection Fraction — all drugs for Preserved Ejection Fraction →

Sponsor

Ascension Macomb-Oakland Hospital

Who can join

Eligibility, any sex, with Heart Failure or Preserved Ejection Fraction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective review of 492 patient from a small community hospital who did not qualify for participation in the Connect HF study sponsored by DCRI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04008914 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ascension Macomb-Oakland Hospital
Last refreshed: 8 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04008914.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing